keyword
Keywords cancer, malignant, oncology, h...

cancer, malignant, oncology, hematology, chemotherapy

https://read.qxmd.com/read/38605511/results-of-a-long-term-prospective-study-on-complications-of-central-venous-catheter-in-pediatric-patients-with-hematologic-oncologic-diseases
#1
JOURNAL ARTICLE
Chiara Garonzi, Francesca Zeni, Gloria Tridello, Alice Giacomazzi, Alberto Castagna, Maria Pia Esposto, Giulia Caddeo, Vincenza Pezzella, Ada Zaccaron, Elisa Bonetti, Virginia Vitale, Matteo Chinello, Rita Balter, Beatrice Guardini, Eleonora Pedrazzoli, Simone Cesaro
BACKGROUND: Central venous catheter (CVC)-related complications remain a significant cause of morbidity in pediatric hematology-oncology. We prospectively surveyed the incidence of CVC-related complications in children with hematologic-oncologic diseases. PROCEDURE: Five-hundred-eighty-one CVCs were inserted in 421 patients from January 2010 to June 2022 (153,731 CVC days observation; follow-up data up to December 31, 2022). RESULTS: Overall, 671 complications were recorded (4...
April 11, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38595820/case-report-therapy-related-myeloid-neoplasms-in-three-pediatric-cases-with-medulloblastoma
#2
Li Shun Mak, Xiuling Li, Wilson Y K Chan, Alex W K Leung, Daniel K L Cheuk, Liz Y P Yuen, Jason C C So, Shau Yin Ha, Anthony P Y Liu
INTRODUCTION: Medulloblastoma is the most common malignant brain tumor in children, often requiring intensive multimodal therapy, including chemotherapy with alkylating agents. However, therapy-related complications, such as therapy-related myeloid neoplasms (t-MNs), can arise, particularly in patients with genetic predisposition syndromes. This case report presents three pediatric cases of medulloblastoma with subsequent development of t-MNs, highlighting the potential role of genetic predisposition and the importance of surveillance for hematological abnormalities in long-term survivors...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38576044/long-term-cardiac-effects-of-modern-treatment-for-hodgkin-s-lymphoma
#3
JOURNAL ARTICLE
Anders W Bjerring, Knut Hb Smeland, Thomas Stokke, Kristina H Haugaa, Espen Holte, Assami Rösner, Cecilie E Kiserud, Thor Edvardsen, Sebastian Imre Sarvari
BACKGROUND: Hodgkin's lymphoma (HL) is a hematological malignancy that affects both children and young adults. Traditional treatment is associated with a life-time prevalence of cardiac disease exceeding 50%. In the late 1990s protocols were modified to reduce cancer therapy-related adverse cardiac effects. This study aimed to assess the long-term impact of advances in treatment protocols on the cardiac health of HL survivors (HLS). METHODS: HLS (n = 246) treated between 1997 and 2007 with anthracycline-based chemotherapy in three centers in Norway were included...
April 4, 2024: Cardio-Oncology
https://read.qxmd.com/read/38575837/fertility-preservation-in-hematological-cancer-patients
#4
REVIEW
Dan Li, Yi-Jun Zhao, Qian Wang, Man-Wei Chu, Juan-Ke Xie, Cui-Lian Zhang
Among adolescents and young adults, hematological malignancies are the most common malignancies. Although the survival rate of hematological malignancies in young patients has been dramatically improved, due to the continuous improvement and development of tumor diagnosis and treatment options, cytotoxic therapies can significantly reduce a patient's reproductive capacity and cause irreversible infertility. The most two established solutions are embryo cryopreservation and oocyte cryopreservation which can be considered in single female...
April 4, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38572064/secondary-hematological-malignancies-in-patients-with-sarcoma-a-single%C3%A2-center-retrospective-study
#5
JOURNAL ARTICLE
Yoon Jung Jang, Hong Kyu Jeong, Chang-Bae Kong, Won Seok Song, Wan Hyeong Cho, Dae Geun Jeon, Heyjin Kim, Sung Hyun Yang, Im Il Na, Hyo-Rak Lee, Hye Jin Kang
The present retrospective study investigated the clinical features and prognosis of secondary hematological malignancies (SHMs) in patients with sarcoma at Korea Cancer Center Hospital (Seoul, South Korea). Patients who had been diagnosed with SHMs after having received treatment for sarcoma between January 2000 and May 2023 were enrolled. Clinical data were collected from the patients' medical records. Clinical characteristics were analyzed, including SHM incidence, type and prognosis. Of 2,953 patients with sarcoma, 18 (0...
May 2024: Oncology Letters
https://read.qxmd.com/read/38535043/determination-of-l-asparaginase-activity-and-its-therapeutic-monitoring-in-children-with-hematological-malignancies-in-a-single-croatian-center
#6
JOURNAL ARTICLE
Jasna Lenicek Krleza, Ana Katusic Bojanac, Gordana Jakovljevic
BACKGROUND: Among malignant diseases which develop during childhood, hematological cancers, such as leukemias and lymphomas, are the most common. Outcomes have greatly improved due to the refinement of multiagent chemotherapy regimens that include enhanced asparaginase therapy. In this study, we aimed to evaluate our experiences related to the analytical and clinical significance of determining l-Asparaginase activity. METHODS: Since 2016, the Laboratory of the Children's Hospital Zagreb has routinely measured l-Asparaginase activity and to date, has measured more than 280 examples of activity in a total of 57 children with hematological malignancy treated at the Pediatric Oncology Department of the Children's Hospital Zagreb...
March 15, 2024: Diagnostics
https://read.qxmd.com/read/38529460/vitamin-d-deficiency-in-pediatric-oncology-patients-a-single-center-experience-in-saudi-arabia
#7
JOURNAL ARTICLE
Dania A Monagel, Amal O Albaity, Fatimah M Asiri, Lama N Alghamdi, Raghad A Alsufyani, Reem B Alqarni, Shaden K Bahatheq, Omaima Ahmed, Naglla Elimam, Alaa Althubaiti
Background There is a lack of local studies on vitamin D deficiency in children with cancer. This study aims to estimate the prevalence of vitamin D deficiency in the pediatric oncology population at King Abdul-Aziz Medical City (KAMC) in Jeddah, addressing knowledge gaps for improved clinical practice and future research. Methods This retrospective observational study was conducted from 2016 to 2021 at the pediatric oncology clinic in National Guard Hospital, Jeddah. The study focused on children aged 14 or younger at cancer diagnosis, data encompassed patient demographics, cancer details, and treatment information, including serum measurements of vitamin D (25(OH)D, calcium, phosphate, alkaline phosphatase)...
February 2024: Curēus
https://read.qxmd.com/read/38512893/screening-for-viral-hepatitis-b-infection-in-cancer-patients-before-receiving-chemotherapy-a-systematic-review-and-meta-analysis
#8
REVIEW
Soe Thiha Maung, Natee Deepan, Pakanat Decharatanachart, Roongruedee Chaiteerakij
AIM: We conducted a systematic review and meta-analysis to assess the hepatitis B virus (HBV) screening rate in cancer patients before systemic chemotherapy, aiming to identify those needing antiviral prophylaxis for HBV reactivation. METHODS: We searched PubMed, Embase, Scopus, and Google Scholar for relevant studies. The pooled screening rate was estimated using a random effects model. Subgroup analyses were conducted based on malignancy types, chemotherapy regimens, study period, and HBV endemic regions...
March 21, 2024: Asia-Pacific Journal of Clinical Oncology
https://read.qxmd.com/read/38495640/fear-of-cancer-recurrence-and-associated-factors-in-family-caregivers-of-patients-with-hematologic-malignancy-receiving-chemotherapy-a-latent-profile-analysis
#9
JOURNAL ARTICLE
Li Sheng, Yingying Zhu, Yajiao Liu, Haiying Hua, Jingfen Zhou, Long Ye
OBJECTIVE: This study identified the potential subgroups of fear of cancer recurrence (FCR) in family caregivers (FCs) of patients with hematologic malignancies receiving chemotherapy, as well as exploring factors associated with subgroups. METHODS: This was a cross-sectional study involving 206 pairs of participating patients with hematologic malignancies receiving chemotherapy and their FCs. Using Mplus 8.3 to perform the latent profile analysis of FCs' FCR, the FCs' burden, quality of life, psychological resilience, and anxiety as well as their demographic characteristics were compared between the subgroups, with a logistic regression analysis being applied to examine the factors associated with the FCR subgroups...
April 2024: Asia-Pacific Journal of Oncology Nursing
https://read.qxmd.com/read/38486856/advancements-in-chimeric-antigen-receptor-expressing-t-cell-therapy-for-glioblastoma-multiforme-literature-review-and-future-directions
#10
REVIEW
Michael Goutnik, Alexandria Iakovidis, Megan E H Still, Rachel S F Moor, Kaitlyn Melnick, Sandra Yan, Muhammad Abbas, Jianping Huang, Ashley P Ghiaseddin
Glioblastoma multiforme (GBM) is an aggressive cancer that has been difficult to treat and often requires multimodal therapy consisting of surgery, radiotherapy, and chemotherapy. Chimeric antigen receptor-expressing (CAR-T) cells have been efficacious in treating hematological malignancies, resulting in several FDA-approved therapies. CAR-T cells have been more recently studied for the treatment of GBM, with some promising preclinical and clinical results. The purpose of this literature review is to highlight the commonly targeted antigens, results of clinical trials, novel modifications, and potential solutions for challenges that exist for CAR-T cells to become more widely implemented and effective in eradicating GBM...
2024: Neuro-oncology advances
https://read.qxmd.com/read/38462149/multi-disciplinary-management-of-esophageal-carcinoma-current-practices-and-future-directions
#11
REVIEW
Chanyoot Bandidwattanawong
Esophageal cancer in one of the most malignant and hard-to-treat cancers. Esophageal squamous carcinoma (ESCC) is most common in Asian countries, whereas adenocarcinoma at the esophago-gastric junction (EGJ AC) is more prevalent in the Western countries. Due to differences in both genetic background and response to chemotherapy and radiotherapy, both histologic subtypes need different paradigms of management. Since the landmark CROSS study has demonstrated the superior survival benefit of tri-modality including neoadjuvant chemoradiotherapy prior to esophagectomy, the tri-modality becomes the standard of care; however, it is suitable for a highly-selected patient...
March 8, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38456710/advanced-strategies-in-improving-the-immunotherapeutic-effect-of-car-t-cell-therapy
#12
REVIEW
Minmin Wang, Linzi Jia, Xiangpeng Dai, Xiaoling Zhang
Chimeric antigen receptor (CAR-T) cell therapy is a newly developed immunotherapy strategy and has achieved satisfactory outcomes in the treatment of hematological malignancies. However, some adverse effects related to CAR-T cell therapy have to be resolved before it is widely used in clinics as a cancer treatment. Furthermore, the application of CAR-T cell therapy in the treatment of solid tumors has been hampered by numerous limitations. Therefore, it is essential to explore novel strategies to improve the therapeutic effect of CAR-T cell therapy...
March 8, 2024: Molecular Oncology
https://read.qxmd.com/read/38454222/the-frequency-severity-and-risk-factors-of-hickman-catheterrelated-complications-in-pediatric-cancer-patients-a-single-center-experience-from-bosnia-and-herzegovina
#13
JOURNAL ARTICLE
Zlatan Zvizdic, Emin Zaimovic, Emir Milisic, Asmir Jonuzi, Una Glamoclija, Semir Vranic
OBJECTIVE: This study aimed to identify the frequency, severity, and risk factors associated with Hickman catheter-related complications in children with hemato-oncological malignancies at the largest pediatric tertiary care unit in Bosnia and Herzegovina. MATERIALS AND METHODS: A cross-sectional study was conducted on a cohort of pediatric cancer patients who underwent Hickman central venous catheters (CVCs) between January 2019 and December 2022. Mechanical, infectious, and thrombotic Hickman catheter-related complications were evaluated and analyzed...
March 2024: Turkish archives of pediatrics
https://read.qxmd.com/read/38450195/current-treatment-strategies-targeting-histone-deacetylase-inhibitors-in-acute-lymphocytic-leukemia-a-systematic-review
#14
REVIEW
Yingjun Zhang, Ge Zhang, Yuefang Wang, Lei Ye, Luyun Peng, Rui Shi, Siqi Guo, Jiajing He, Hao Yang, Qingkai Dai
Acute lymphocytic leukemia is a hematological malignancy that primarily affects children. Long-term chemotherapy is effective, but always causes different toxic side effects. With the application of a chemotherapy-free treatment strategy, we intend to demonstrate the most recent results of using one type of epigenetic drug, histone deacetylase inhibitors, in ALL and to provide preclinical evidence for further clinical trials. In this review, we found that panobinostat (LBH589) showed positive outcomes as a monotherapy, whereas vorinostat (SAHA) was a better choice for combinatorial use...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38447785/the-association-between-paraneoplastic-neurological-syndromes-pns-and-urothelial-carcinoma-a-review-of-the-literature
#15
REVIEW
Sarafina Urenna Otis, Giuseppe Luigi Banna, Akash Maniam
Paraneoplastic neurological syndromes (PNS) are rare neurological disorders arising from malignancy-triggered autoimmunity, yet their association with urothelial carcinoma remains unclear. This systematic review intends to explore any connection, alongside patient/clinical features and management. A literature search identified 25 cases of bladder and upper tract carcinoma linked to PNS. Overall, while infrequent, a meaningful association between PNS and urothelial carcinoma was found in that 84% of cases met a 'possible'-or-'higher-likelihood' PNS diagnosis...
March 4, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38344690/improving-anticoagulation-care-for-pediatric-oncology-patients-a-quality-improvement-initiative
#16
JOURNAL ARTICLE
Vilmarie Rodriguez, Brockton S Mitchell, Joseph Stanek, Katherine Vasko, Jean Giver, Kay Monda, Joan Canini, Amy A Dunn, Riten Kumar
BACKGROUND: Cancer is associated with increased venous thromboembolism in children. Risk factors for venous thromboembolism in this cohort include using central venous catheters, mass effect from underlying malignancy, chemotherapy, and surgery. Anticoagulation management in this cohort is challenging, given recurrent episodes of thrombocytopenia, the need for invasive procedures, and coagulopathy. A quality improvement (QI) initiative was developed to improve hematology consultation services and provide documentation of an individualized anticoagulation care plan for this high-risk cohort...
2024: Pediatric Quality & Safety
https://read.qxmd.com/read/38322417/sequential-autologous-car-t-and-allogeneic-car-t-therapy-successfully-treats-central-nervous-system-involvement-relapsed-refractory-all-a-case-report-and-literature-review
#17
Yifan Liu, Yanfen Li, Zhangyu Yu, Rongrong Wang, Yu Jing
BACKGROUND: The central nervous system (CNS) is the most common site of extramedullary invasion in acute lymphoblastic leukemia (ALL), and involvement of the CNS is often associated with relapse, refractory disease, and poor prognosis. Chimeric antigen receptor-T (CAR-T) cell therapy, a promising modality in cancer immunotherapy, has demonstrated significant advantages in the treatment of hematological malignancies. However, due to associated adverse reactions such as nervous system toxicity, the safety and efficacy of CAR-T cell therapy in treating CNSL remains controversial, with limited reports available...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38301183/clinical-utility-of-stepwise-bronchoalveolar-lavage-fluid-analysis-in-diagnosing-and-managing-lung-infiltrates-in-leukemia-lymphoma-patients-with-febrile-neutropenia
#18
JOURNAL ARTICLE
Jayashree Thorat, Surabhi Bhat, Manju Sengar, Akshay Baheti, Sweta Bothra, Maheema Bhaskar, Sandeep Prakashnarain Tandon, Sanjay K Biswas, Gaurav V Salunke, George Karimundackal, Virendra Kumar Tiwari, C S Pramesh, Neha Sharma, Venkatesh Kapu, Thomas Eipe, Bhausaheb Pandurang Bagal, Lingaraj Nayak, Avinash Bonda, Amit Janu, Alok Shetty, Hasmukh Jain
PURPOSE: Febrile neutropenia (FN) is a serious complication in hematologic malignancies, and lung infiltrates (LIs) remain a significant concern. An accurate microbiological diagnosis is crucial but difficult to establish. To address this, we analyzed the utility of a standardized method for performing bronchoalveolar lavage (BAL) along with a two-step strategy for the analysis of BAL fluid. PATIENTS AND METHODS: This prospective observational study was conducted at a tertiary cancer center from November 2018 to June 2020...
February 2024: JCO global oncology
https://read.qxmd.com/read/38301180/bacterial-isolates-and-characteristics-of-children-with-febrile-neutropenia-on-treatment-for-cancer-at-a-tertiary-hospital-in-western-kenya
#19
JOURNAL ARTICLE
Samuel Kipkemoi Kipchumba, Festus Muigai Njuguna, Winstone Mokaya Nyandiko
PURPOSE: This study aimed to identify the patient characteristics of children with febrile neutropenia, the associated bacterial organisms, and their sensitivity patterns. MATERIALS AND METHODS: A descriptive cross-sectional study was conducted at the Moi Teaching and Referral Hospital (MTRH) pediatric oncology ward, from June 2021 to April 2022. A total of 110 children who developed fever and neutropenia during chemotherapy were enrolled. Blood samples for culture were collected aseptically...
February 2024: JCO global oncology
https://read.qxmd.com/read/38298432/integrated-analysis-and-validation-reveal-cyth4-as-a-potential-prognostic-biomarker-in-acute-myeloid-leukemia
#20
JOURNAL ARTICLE
Hong Wang, Yishu Xiao, Wei Zhou, Yonghui Li
Acute myeloid leukemia (AML) is a clonal hematological malignancy with high mortality rates. The identification of novel markers is urgent for AML. Cytohesins are a subfamily of guanine nucleotide exchange factors activating the ADP-ribosylation factor family GTPases. While the important roles of cytohesins have been reported in various cancers, their function in AML remains unclear. The present study aimed to explore the prognostic impact of cytohesin-4 (CYTH4) and the underlying molecular functions. RNA sequencing and AML clinical data were obtained from The Cancer Genome Atlas and Gene Expression Omnibus databases to investigate gene expression and survival...
March 2024: Oncology Letters
keyword
keyword
16392
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.